• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性血液透析的透析剂量:超越尿素清除率(Kt/V)

Dialysis dosing for chronic hemodialysis: beyond Kt/V.

作者信息

Daugirdas John T

出版信息

Semin Dial. 2014 Mar;27(2):98-107. doi: 10.1111/sdi.12201.

DOI:10.1111/sdi.12201
PMID:24738145
Abstract

Current views regarding hemodialysis adequacy reach beyond indices of small solute removal such as Kt/V. Nevertheless, new Kt/V-based constructs such as the standard Kt/V, which adjusts not only for dialysis frequency, but which also represents removal of sequestered solutes rather than easily removed urea, continue to be useful. The scaling of dialysis dose to measures of size other than body water results in higher recommended doses of dialysis for children, small patients, and women, compared with the current body water-based scaling approach. Aside from small solute removal, increasing weekly time on dialysis results in slower removal of fluid with better tolerance and with increased removal of phosphorus, although both salt and water and phosphorus control often respond to efforts to reduce intake. The intermediate term benefits of removing larger middle molecules such as beta-2-microglobulin appear to be modest, and the benefits of removal of protein-bound uremic toxins remain to be proved in controlled trials.

摘要

目前关于血液透析充分性的观点已超越诸如Kt/V等小分子溶质清除指标。然而,基于Kt/V的新指标,如标准Kt/V,不仅能根据透析频率进行调整,还能反映被隔离溶质的清除情况,而非易清除的尿素,这些指标仍然有用。与当前基于身体水分的剂量换算方法相比,将透析剂量换算为除身体水分之外的其他尺寸指标,会导致儿童、体型较小的患者和女性的推荐透析剂量更高。除小分子溶质清除外,增加每周透析时间会使液体清除速度减慢,但耐受性更好,同时磷清除增加,尽管盐、水和磷的控制通常会对减少摄入量的努力做出反应。清除较大的中分子物质(如β2微球蛋白)的中期益处似乎不大,而清除与蛋白质结合的尿毒症毒素的益处仍有待在对照试验中得到证实。

相似文献

1
Dialysis dosing for chronic hemodialysis: beyond Kt/V.慢性血液透析的透析剂量:超越尿素清除率(Kt/V)
Semin Dial. 2014 Mar;27(2):98-107. doi: 10.1111/sdi.12201.
2
Effect of Treatment Duration and Frequency on Uremic Solute Kinetics, Clearances and Concentrations.治疗持续时间和频率对尿毒症溶质动力学、清除率和浓度的影响。
Semin Dial. 2016 Nov;29(6):463-470. doi: 10.1111/sdi.12531. Epub 2016 Aug 31.
3
A simple method for the calculation of dialysis Kt factor as a quantitative measure of removal efficiency of uremic retention solutes: Applicability to high-dialysate vs low-dialysate volume technologies.一种简单的透析 Kt 因子计算方法,作为衡量尿毒症潴留溶质清除效率的定量指标:适用于高透析液量与低透析液量技术。
PLoS One. 2020 May 29;15(5):e0233331. doi: 10.1371/journal.pone.0233331. eCollection 2020.
4
Dissociation between dialysis adequacy and Kt/V.透析充分性与Kt/V之间的分离
Semin Dial. 2002 Jan-Feb;15(1):3-7. doi: 10.1046/j.1525-139x.2002.00005.x.
5
Chronic renal replacement therapy in children: which index is best for adequacy?儿童慢性肾脏替代治疗:哪种指标最能评估充分性?
Kidney Int. 1998 Nov;54(5):1690-6. doi: 10.1046/j.1523-1755.1998.00135.x.
6
Dialysis dose as a determinant of adequacy.透析剂量作为充分性的决定因素。
Semin Nephrol. 2005 Mar;25(2):76-80. doi: 10.1016/j.semnephrol.2004.09.013.
7
A sad but forgotten truth: the story of slow-moving solutes in fast hemodialysis.一个悲哀却被遗忘的事实:快速血液透析中缓慢移动溶质的故事。
Semin Dial. 2012 Sep-Oct;25(5):505-9. doi: 10.1111/j.1525-139X.2012.01107.x. Epub 2012 Aug 26.
8
Scaling Hemodialysis Target Dose to Reflect Body Surface Area, Metabolic Activity, and Protein Catabolic Rate: A Prospective, Cross-sectional Study.以体表面积、代谢活性和蛋白质分解率为指标调整血液透析目标剂量:一项前瞻性、横断面研究。
Am J Kidney Dis. 2017 Mar;69(3):358-366. doi: 10.1053/j.ajkd.2016.07.025. Epub 2016 Sep 20.
9
Adequacy in dialysis: intermittent versus continuous therapies.透析充分性:间歇性与连续性治疗
Nefrologia. 2000;20 Suppl 3:25-32.
10
Dialysis cannot be dosed.透析无法定量。
Semin Dial. 2011 Sep-Oct;24(5):471-9. doi: 10.1111/j.1525-139X.2011.00979.x. Epub 2011 Sep 19.

引用本文的文献

1
Effects of hemodialysis adequacy on chronic kidney disease complications using latent class trajectory modeling: a real-world study based on long-term observation of Kt/V.使用潜在类别轨迹模型研究血液透析充分性对慢性肾脏病并发症的影响:一项基于Kt/V长期观察的真实世界研究
Front Med (Lausanne). 2024 Sep 19;11:1449919. doi: 10.3389/fmed.2024.1449919. eCollection 2024.
2
Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine.血液透析治疗的选择:变体、个性化治疗与循证医学的应用
Clin Kidney J. 2021 Dec 27;14(Suppl 4):i45-i58. doi: 10.1093/ckj/sfab198. eCollection 2021 Dec.
3
Residual renal function in incremental haemodialysis.
递增式血液透析中的残余肾功能
Clin Kidney J. 2018 Dec;11(6):857-863. doi: 10.1093/ckj/sfy036. Epub 2018 Jun 12.
4
Weekly Standard Kt/V and Clinical Outcomes in Home and In-Center Hemodialysis.《每周标准 Kt/V 与家庭和中心血液透析的临床结局》。
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):445-455. doi: 10.2215/CJN.05680517. Epub 2018 Jan 11.
5
Dialyzing women and men: does it matter? An observational study.透析的女性和男性:这有关系吗?一项观察性研究。
Clin Kidney J. 2016 Jun;9(3):486-93. doi: 10.1093/ckj/sfw013. Epub 2016 Apr 7.
6
Body composition monitoring-derived urea distribution volume in children on chronic hemodialysis.慢性血液透析儿童身体成分监测得出的尿素分布容积
Pediatr Nephrol. 2016 Jun;31(6):991-9. doi: 10.1007/s00467-015-3283-3. Epub 2016 Jan 11.
7
Kt/V (and especially its modifications) remains a useful measure of hemodialysis dose.Kt/V(尤其是其改良形式)仍然是衡量血液透析剂量的有用指标。
Kidney Int. 2015 Sep;88(3):466-73. doi: 10.1038/ki.2015.204. Epub 2015 Jul 15.